Metabolic biomarkers in lung cancer screening and early diagnosis (Review)
Oncology Letters · 03.05.2023 · 25 (6)
DOI: 10.3892/ol.2023.13851 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Letters, online erschienen am 03.05.2023. Verfasst von Yongjie Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences …. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China.
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China.
Zitieren
APA
Xu, Y., Dong, X., Qin, C., Wang, F., Cao, W., Li, J., Yu, Y., Zhao, L., Tan, F., Chen, W., Li, N., & He, J. (2023). Metabolic biomarkers in lung cancer screening and early diagnosis (Review). Oncology Letters, 25(6). https://doi.org/10.3892/ol.2023.13851
Vancouver
Xu Y, Dong X, Qin C, Wang F, Cao W, Li J, et al. Metabolic biomarkers in lung cancer screening and early diagnosis (Review). Oncology Letters. 2023;25(6). doi:10.3892/ol.2023.13851
BibTeX
@article{Xu2023,
author = {Xu, Yongjie and Dong, Xuesi and Qin, Chao and Wang, Fei and Cao, Wei and Li, Jiang and Yu, Yiwen and Zhao, Liang and Tan, Fengwei and Chen, Wanqing and Li, Ni and He, Jie},
title = {Metabolic biomarkers in lung cancer screening and early diagnosis (Review)},
journal = {Oncology Letters},
year = {2023},
volume = {25},
number = {6},
doi = {10.3892/ol.2023.13851}
}
EUVIMED